GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Inventories, Other

LakeShore Biopharma Co (LakeShore Biopharma Co) Inventories, Other : $29.16 Mil (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. LakeShore Biopharma Co's other inventories for the quarter that ended in Sep. 2023 was $29.16 Mil.

LakeShore Biopharma Co's quarterly other inventories increased from Sep. 2022 ($0.00 Mil) to Mar. 2023 ($0.00 Mil) and increased from Mar. 2023 ($0.00 Mil) to Sep. 2023 ($29.16 Mil).

LakeShore Biopharma Co's annual other inventories stayed the same from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.00 Mil) but then increased from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($0.00 Mil).


LakeShore Biopharma Co Inventories, Other Historical Data

The historical data trend for LakeShore Biopharma Co's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Inventories, Other Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23
Inventories, Other
- - -

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Inventories, Other Get a 7-Day Free Trial - - - - 29.16

LakeShore Biopharma Co Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.